| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/06/2002 | US20020068717 Methods and compositions for enhancing diffusion of therapeutic agents through tissue |
| 06/06/2002 | US20020068693 Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| 06/06/2002 | US20020068641 Roller coaster based simulator for amusement and flight training |
| 06/06/2002 | US20020068365 Time released composition for use in the treatment of sexual disorder |
| 06/06/2002 | US20020068151 Multi-layered, air-gapped sheet of chitosan |
| 06/06/2002 | US20020068096 Antimonocytic activity of betel leaf extracts |
| 06/06/2002 | US20020068092 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 06/06/2002 | US20020068090 Useful in vaccines, as carriers for native and recombinant antigens; for treatment of herpes-simplex-virus-2 |
| 06/06/2002 | US20020068089 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/06/2002 | US20020068088 Easy to swallow oral medicament composition |
| 06/06/2002 | US20020068087 Bioadhesive hydrogels with functionalized degradable crosslinks |
| 06/06/2002 | US20020068085 Three dosages forms having different release profile, extending dosage to twelve hours |
| 06/06/2002 | US20020068084 Pharmaceutical superdisintegrant |
| 06/06/2002 | US20020068083 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 06/06/2002 | US20020068082 Viscosity of liquid provides buoyancy to solid (drug/supplement), and wettability allows solid to be engulfed by liquid; solid floats through liquid and does not become lodged in tongue, throat or palate |
| 06/06/2002 | US20020068080 Administering pharmaceuticals to the mammalian central nervous system |
| 06/06/2002 | US20020068078 Antifungal product, use and formulation thereof |
| 06/06/2002 | US20020068077 Methods and compositions for reducing side effects in chemotherapeutic treatments |
| 06/06/2002 | US20020068076 Cosmetic composition in the form of a soft paste and process for preparation of same |
| 06/06/2002 | US20020068072 Treating lichens, prurigo, pruriginous toxicoderma and severe pruritus of neurogenic origin |
| 06/06/2002 | US20020068065 Pharmaceutical composition having specific water activity |
| 06/06/2002 | US20020066978 Method of forming articles including waveguides via capillary micromolding and microtransfer molding |
| 06/06/2002 | DE10060470A1 Thermoplastische und wasserlösliche Celluloseether-ester Thermoplastic and water-soluble cellulose ether-ester |
| 06/06/2002 | DE10059430A1 Feinteilige Emulsionen Fine-particle emulsions |
| 06/06/2002 | DE10059239A1 Kosmetische und/oder pharmazeutische Emulsionen Cosmetic and / or pharmaceutical emulsions |
| 06/06/2002 | DE10058772A1 Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen Process for the preparation of highly soluble drug formulations and corresponding formulations |
| 06/06/2002 | DE10058771A1 Coazervierungsverfahren zur Herstellung von verzögert feisetzenden Arzneimitteln Coazervierungsverfahren for producing delayed feisetzenden drugs |
| 06/06/2002 | DE10058384A1 Kosmetisches oder dermatologisches Mittel in Form eines cremigen Permanentschaums oder einer stabil aufgeschäumten Creme Cosmetic or dermatological agent in the form of a creamy permanent foam or stable foamed cream |
| 06/06/2002 | DE10057290A1 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten To be administered enterally supplement for parenteral nutrition or partial enteral / oral nutrition in critically ill patients, chronically ill and malnourished |
| 06/06/2002 | DE10051858A1 Verwendung von biologisch abbaubaren, substituierten Kohlenwasserstoffen deren Ester, Ether und/oder Amide als Nasensalbe oder Nasentropfen zur Prophylaxe von inhalationsallergischen Reaktionen und zur Pflege der Nasenschleimhaut Use of biologically degradable, substituted hydrocarbons their esters, ethers and / or amides as a nasal ointment or nasal drops for the prophylaxis of inhalation allergic reactions and for the care of the nasal mucosa |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2689915A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2625277A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/06/2002 | CA2436882A1 Dispensing device |
| 06/06/2002 | CA2436348A1 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | CA2433668A1 Prolamin-based sustained-release compositions and delayed-onset compositions |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430286A1 W/o/w composite emulsion |
| 06/06/2002 | CA2430139A1 Stable, aerosolizable suspensions of proteins in ethanol |
| 06/06/2002 | CA2430137A1 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| 06/06/2002 | CA2430039A1 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | CA2429945A1 Devices and methods for controlled delivery from a drug delivery device |
| 06/06/2002 | CA2429943A1 Method and apparatus for delivery of therapeutic from a delivery matrix |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429665A1 Method of making particles for use in a pharmaceutical composition |
| 06/06/2002 | CA2428445A1 Improved pullulan free edible film compositions and methods of making the same |
| 06/06/2002 | CA2427618A1 Composition containing statins and calcium for improved cardiovascular health |
| 06/06/2002 | CA2427255A1 Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 06/05/2002 | EP1211258A1 Process for preparing solubilizing adjuvants from fusel oils and oses |
| 06/05/2002 | EP1210947A1 Ophthalmic ointments for treating infective eye diseases |
| 06/05/2002 | EP1210944A1 Blood plasma replacement solution |
| 06/05/2002 | EP1210943A1 New use for budesonide and formoterol |
| 06/05/2002 | EP1210942A2 Microparticles |
| 06/05/2002 | EP1210939A2 Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof |
| 06/05/2002 | EP1210937A2 Device for topical treatment of acne and its method of manufacture |
| 06/05/2002 | EP1210936A1 Gelatin capsule |
| 06/05/2002 | EP1210935A1 Medicinal compositions for oral use |
| 06/05/2002 | EP1210934A2 Pharmaceutical carrier preparation applicable to mucosal surfaces and body tissues |
| 06/05/2002 | EP1210929A2 Cosmetic compositions comprising alkyl or alkenyl derivatives of succinic acid |
| 06/05/2002 | EP1210361A1 Stabilisation of freeze-dried cake |
| 06/05/2002 | EP1210182A1 Permeabilizing biofilms |
| 06/05/2002 | EP1210138A1 Controlled delivery of bisphosphonates |
| 06/05/2002 | EP1210130A1 Solid wound healing formulations containing fibronectin |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210104A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 06/05/2002 | EP1210099A1 Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras |
| 06/05/2002 | EP1210092A1 Calcium-containing structures and methods of making and using the same |
| 06/05/2002 | EP1210091A1 Heartburn treatment |
| 06/05/2002 | EP1210085A2 Pharmaceutical solutions of levosimendan |
| 06/05/2002 | EP1210081A2 Combination of active agents, said combination containing clonidine |
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1210076A2 Drug therapy of the restless leg syndrome |
| 06/05/2002 | EP1210075A1 Compositions and methods for modification of skin lipid content |
| 06/05/2002 | EP1210074A2 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 06/05/2002 | EP1210072A1 Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 06/05/2002 | EP1210071A1 Method for improving and maintaining bowel function as well as a method for the production thereof |
| 06/05/2002 | EP1210070A1 Agent for stimulating bowel function and method for producing the same |
| 06/05/2002 | EP1210069A2 Large porous particles by spray-drying |
| 06/05/2002 | EP1210068A2 Use of simple amino acids to form porous particles |
| 06/05/2002 | EP1210067A2 Modulation of release from dry powder formulations |
| 06/05/2002 | EP1210066A1 Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants |
| 06/05/2002 | EP1210065A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 06/05/2002 | EP1210064A1 Thermally-activated microchip chemical delivery devices |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1210046A1 Enhanced wound coverage to enhance wound healing |
| 06/05/2002 | EP1210040A2 Apparatus and method for anesthetizing the cervical region of a female |
| 06/05/2002 | EP1210036A1 Composite shaped bodies and methods for their production and use |
| 06/05/2002 | EP1209988A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 06/05/2002 | EP1209986A1 Metal-containing compositions, preparations and uses |
| 06/05/2002 | EP1121144B1 Stable concentrated insulin preparations for pulmonary delivery |
| 06/05/2002 | EP1121117B1 Oxaliplatinum preparation packaging |
| 06/05/2002 | EP1121112B1 Stable formoterol concentrate |
| 06/05/2002 | EP0946139B1 Pharmaceutical formulation |
| 06/05/2002 | EP0930888B1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 06/05/2002 | EP0889723B1 Transdermal therapeutic system with small application-area thickness and great flexibility, and production process |
| 06/05/2002 | EP0879057B1 Granules from triazines |
| 06/05/2002 | EP0804228B1 Medicament containing protein C activation peptide |
| 06/05/2002 | EP0799046B1 Stable solutions of 2-chloro-2'-deoxyadenosine |
| 06/05/2002 | EP0789580B1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |